Holen Sie sich die Stockscreener-App
207.51
1.42%
2.90
Handel nachbörslich:
207.51
Schlusskurs vom Vortag:
$204.61
Offen:
$200.88
24-Stunden-Volumen:
786.84K
Relative Volume:
0.62
Marktkapitalisierung:
$17.13B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$747.89M
KGV:
33.47
EPS:
6.2
Netto-Cashflow:
$1.23B
1W Leistung:
-0.31%
1M Leistung:
+1.89%
6M Leistung:
-34.33%
1J Leistung:
-25.73%
1-Tages-Spanne:
$200.69
$210.05
1-Wochen-Bereich:
$200.69
$211.76
52-Wochen-Spanne:
$183.38
$347.72
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ICLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
207.51 | 17.13B | 8.31B | 747.89M | 1.23B | 8.97 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR
ICON plc Appoints Barry Balfe as Chief Operating Officer - TipRanks
ICON plc appoints Barry Balfe as new COO - Investing.com
ICON Appoints 20-Year Veteran Barry Balfe as Chief Operating Officer to Drive Strategic Growth - StockTitan
ICON's SWOT analysis: CRO giant navigates turbulent market - Investing.com
ICON plc Announces Appointment of Barry Balfe as Chief Operating Officer - Marketscreener.com
October 2025 Options Now Available For Icon - Nasdaq
Contract Research Organization Services Market Set to Witness Significant Growth by 2024-2031: IQVIA, LabCorp, - EIN News
ICON's SWOT analysis: cro stock navigates challenges amid industry shifts - Investing.com
Preclinical Assets Market CAGR of 7.5% Size, Share, Trends, Future Prospect By 2024-2031 | Eurofins - EIN News
Biomarker Research Services Market Set to Witness Significant Growth by 2024-2031:Reprocell Corporation, - EIN News
ICON Public Limited Company (ICLR) Fell on Reduced Guidance - Insider Monkey
Virtual Clinical Trials Market Key Players AnalysisICON, plc; Parexel International Corporation; IQVIA; Covance. - openPR
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption - sharewise
ICON Survey: 82% of Pharma Leaders See AI Boosting R&D Returns as Digital Investment Surges 34% - StockTitan
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors - GlobeNewswire Inc.
Top 30 IQVIA Competitors & Alternatives in [year] - Marketing91
Icon PLC (ICLR) Down 4.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Should You Retain Your Conviction in Icon Plc (ICLR)? - Yahoo Finance
ICON stock labeled a "Fresh Pick" as Baird bets on recovery at current valuation - Investing.com
Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech GiantsArisEurope, ICON plc and Syneos Health | The Insight Partners - GlobeNewswire
Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - MSN
ICON Public Limited (NASDAQ:ICLR) Shares Sold by Entropy Technologies LP - MarketBeat
Prudential expands preferred healthcare network in partnership with Icon Cancer Centre - Media OutReach
ICON Plc stock hits 52-week low at $208.38 amid market shifts - Investing.com India
ICON to Present at London Healthcare Conference - TipRanks
ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
Icon Plc (ICLR-Q) QuotePress Release - The Globe and Mail
Rose Kidd, ICON – Winner of WMB Businesswoman Award 2024 - Women Mean Business
Icon PLC (ICLR) Shares Up 3.48% on Nov 6 - GuruFocus.com
Life Sciences BPO Market Set to Witness Significant Growth by 2024-2031:Catalent, Inc., Covance, Inc., Fareva, - EIN News
Contract Research Organization Services Market Business - openPR
Icon (FRA:IJF) GF Value Rank : 10 (As of Nov. 04, 2024) - GuruFocus.com
ICON Plc stock touches 52-week low at $219.87 amid market shifts - Investing.com Australia
Icon PLC (ICLR) Trading 3.72% Higher on Oct 2 - GuruFocus.com
ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls - Yahoo Finance
ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? - Yahoo Finance UK
ICON perks up after $250M share buyback - MSN
Baird Downgrades ICON Public Limited (ICLR) - MSN
Icon plc Strengthens Investor Confidence with Secured Notes - TipRanks
Earnings call: ICON PLC faces headwinds, eyes strategic growth By Investing.com - Investing.com Australia
Earnings call: ICON PLC faces headwinds, eyes strategic growth - Investing.com India
Icon Earnings: Shares Tank as Elevated Cancellations Reduce 2024 Guidance - Morningstar
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
ICON Public Limited Company (NASDAQ:ICLR) Q3 2024 Earnings Call Transcript - Insider Monkey
Pharmaceutical Contract Sales Outsourcing (CSO) Market Projected To Witness Substantial Growth, 2024-2031: - EIN News
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com
ICON Plc stock touches 52-week low at $227.56 amid market shifts - Investing.com Australia
U.S. Markets Finished Mixed Thursday As Tesla Led, Icon PLC Lagged - Barron's
ICON stock slips after guidance cut (ICLR:NASDAQ) - Seeking Alpha
Icon PLC Down Over 19%, on Pace for Largest Percent Decrease Since March 1999 — Data Talk - Morningstar
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):